JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 24, 2007; DOI: 10.1124/jpet.107.131342

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.131342v1
jpet.107.131342v2
324/1/86    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rius, M.
Right arrow Articles by Keppler, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rius, M.
Right arrow Articles by Keppler, D.


Received for publication September 7, 2007.
Revised October 18, 2007.
Accepted for publication October 22, 2007.

ATP-dependent Transport of Leukotrienes B4 and C4 by the Multidrug Resistance Protein ABCC4 (MRP4)

Maria Rius 1*, Johanna Hummel-Eisenbeiss 1, Dietrich Keppler 2

1 Deutsches Krebsforschungszentrum 2 Deutches Krebsforshungszentrum

* Address correspondence to: E-mail: m.rius{at}dkfz.de

Abstract

The proinflammatory mediators leukotriene (LT) B4 and LTC4 must be transported out of cells before they can interact with LT receptors. Previously, we identified the multidrug resistance protein ABCC1 (MRP1) as an efflux pump for LTC4. However, the molecular basis for the efflux of LTB4 was unknown. Here we demonstrate that human ABCC4 mediates the ATP-dependent efflux of LTB4 in the presence of reduced glutathione (GSH), whereby the latter can be replaced by S-methyl GSH. Transport studies were performed with inside-out membrane vesicles from V79 fibroblasts and Sf9 insect cells that contained recombinant ABCC4, with vesicles from human platelets and myelomonocytic U937 cells, which were rich in endogenous ABCC4 whereas ABCC1 was below detectability. Moreover, human polymorphonuclear leukocytes contained ABCC4. Km values for LTB4 were 5.2 µM with vesicles from fibroblasts and 5.6 µM with vesicles from platelets. ABCC4, with its broad substrate specificity, also functioned as an ATP-dependent efflux pump for LTC4 with a Km of 0.13 µM in vesicles from fibroblasts and 0.32 µM in vesicles from platelets. However, GSH was not required for the transport of this glutathionylated leukotriene. The transport of LTC4 by ABCC4 explains its release from platelets during transcellular synthesis. ATP-dependent transport of LTB4 and LTC4 by ABCC4 was inhibited by several organic anions, including S-decyl GSH, sulindac sulfide, and by the LTD4 receptor antagonists montelukast and MK571. Thus, as an efflux pump for the proinflammatory mediators LTB4 and LTC4, ABCC4 may represent a novel target for anti-inflammatory therapies.


Key words: ABC transporters, anti-inflammatory drugs, glutathione, leukotrienes, membrane transport, multidrug resistance proteins


This article has been cited by other articles:


Home page
 Cancer Res.Home page
Md. T. Hoque and S. P.C. Cole
Down-regulation of Na+/H+ Exchanger Regulatory Factor 1 Increases Expression and Function of Multidrug Resistance Protein 4
Cancer Res., June 15, 2008; 68(12): 4802 - 4809.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.